Molecular diagnosis of Myotonic Dystrophy (DM) in Costa Rica

Authors

  • Fernando Morales Montero Universidad de Costa Rica
  • Patricia Cuenca Berger Universidad de Costa Rica
  • Roberto Brian Gago Caja Costarricense del Seguro Social, Hospital Nacional de Niños "Dr. Carlos Sáenz Herrera"
  • Mauricio Sittenfeld Appel Caja Costarricense del Seguro Social, Hospital San Juan de Dios
  • Gerado Del Valle Carazo Caja Costarricense del Seguro Social, Hospital San Juan de Dios

DOI:

https://doi.org/10.51481/amc.v43i4.75

Keywords:

Distrofia miotónica, mutaciones inestables, anticipación genética, Costa Rica, Hibridación de Southern, PCR, PROMM, consejo genético

Abstract

Myotonic dystrophy (MD) is a multisystemic disease with an autosomal dominant inheritance. The genetic defect is an unstable mutation due to the expansion of the triplet CTG in the 3' unstranslated region (3' UTR) of the DMPK gene on chromosome 19q13.3. The objective of this work was to implement the molecular diagnosis of the disease in order to improve the clinical management and the genetic counseling of fered to patients and their families. This study was based in those patients with clinical diagnosis of DM and their rela-tives. Two technical diagnostic procedures were used, Sout-hern blot and PCR for confirming the clinical diagnosis. We studied 84 members from 21 different families, obtaining the following results: 21 asymptomatic individuals without the mutation (normal), 34 have the mutation (4 of them are still asymptomatic) and 29 patients in 8 families with a previous clinical diagnosis of DM do not have the DM mutation. The size of the mutation is positively correlated with severity of the symptoms. Those cases with no DM mutation probably correspond to other mutations, such as PROMM/DM2 or other inherited myotonies. Molecular diagnosis must be used as a tool for propering a clinical classification of the patients. The adequate clinical approach, since there is no treatment so far, should include, besides a multydisciplinary clinical mana-gement, prevention through genetic counseling based on the exact molecular diagnosis of the carriers.

Downloads

Download data is not yet available.

References

Zerylnick C, Torroni A, Sherman SL, Warren ST. Normal variation at the myotonic dystrophy locus in global human populations. Am J Hum Genet 1995; 56: 123-130.

Krahe R, Eckhart M, Ogunniyi A O, Osuntokun B O, Siciliano M, Ashi-zawa T. De novo myotonic dystrophy mutation in a Nigerian kindred. Am J Hum Genet 1995; 56: 1067-1074.

Harris S, Moncrieff C, Johnson K. Myotonic dystrophy: will the real gene please step forward. Hum Mol Genet 1996; 5: 1417-1423.

Aslanidis C, Jansen G, Amemiya C, Shutler G, Mahadevan M, Tsilfidis C, et al. Cloning of the essential myotonic dystrophy region and map-ping of the putative defect. Nature 1992; 355 (6): 548-551.

Buxton J, Shelbourne P, Davies J, Jones C, Van Tongeren T, Aslanidis C, et al. Detection of an unstable fragment of DNA specific to indivi-duals with DM. Nature 1992; 355: 547-548.

Fu Y H, Pizzuti A, Fenwick R G, King J Jr, Rajnarayan S, Dunne O W, et al. An unstable triplet repeat in a gene related to myotonic muscular distrophy. Science 1992; 255: 1256-1258.

Harley H, Brook J. D, Rundle S, Crow S, Reardon W, Buckler A, et al. Expansion of an unstable DNA region and phenotypic variation in DM. Nature 1992; 355: 545-546.

Mahadevan M, Tsilfidis C, Sabourin L, Shutler G, Amemiya C, Jansen G, et al. Myotonic distrophy mutation: An unstable CTG repeat in the 3 untranslated region of the gene. Science 1992; 255: 1253-1255.

Meiner A, Wolf C, Carey N, Okitsu A, Johnson K, Shelbourne P, et al. Direct molecular analysis of myotonic dystrophy in the german popu-lation: important considerations in genetic counselling. J Med Genet 1995; 32: 645-649.

Jansen G, Willems P, Coerwinkel M, Nillesen W, Smeets H, Vits L, et al. Gonosomal mosaicism in DM patients: Involvement of mitotic events in (CTG)n repeat variation and selection against extreme expan-sion in sperm. Am J Hum Genet 1994; 54: 575-585.

Hecht B K, Donnelly A, Gedeon A K, Byard R W, Haan E A, Mulley J C. Direct molecular diagnosis of the myotonic dystrophy. Clin Genet 1993; 43: 276-285.

Lavedan C, Hofmann-Radvanyi H, Shellbourne P, Rabes J, Duros C, Savoi D, et al. Myotonic dystrophy: size and sex-dependent dynamics of CTG meiotic instability, and somatic mosaicism. Am J Hum Genet 1993; 52: 875-883.

Thornton C, Wymer P J, Simmons Z, McClain C, Moxley III R. Expan-sion of the myotonic dystrophy CTG repeat reduces expresion of the flanking DMAHP gene. Nat Genet 1997; 16: 407-409.

Caskey C T, Swanson M S, Timchenko L T. Myotonic dystrophy: dis-cussion of the molecular mechanism. Cold. Spring. Harb. Symp. Quant Biol 1996; 61: 607-613.

Johnson K J, Boucher C A, King S K, Winchester CL, Bailey M E S, Hamilton G M, et al. Is myotonic dystrophy a single-gene disorder?. Biochem Soc Trans 1996; 24: 510-513.

Bhagwati S, Leung B, Shaquif S, Ghatpande A. Myotonic dystrophy: decreased levels of myotonin protein kinase (Mt-PK) leads to apoptosis in muscle cells. Exper Neurology 1997; 146: 277- 281.

Chahine M, George Jr LA. Myotonic dystrophy kinase modulates skele-tal muscle but not cardiac voltage-gated sodium chanels. FEBS Letters 1997; 412: 621-624.

Taneja KL, McCurrach M, Schalling M, Housman D, Singer R. Foci of trinucleotide repeat tanscripts in nuclei of DM cells and tissues. J Cell Biol 1995; 128: 995-1002.

Ishii S, Nishio T, Sunohara N, Yoshihara T, Takemura K, Hikiji K, et al. Small increase in triplet lenght of cerebellum from patients with myotonic dystrophy. Hum Genet 1996; 98: 138-140.

Sambrook J, Fritsch E. F & Maniatis T. Molecular cloning. A labora-tory manual. 2da Ed. New York: Cold Sping Harbor Laboratory Press, 1989.

Shelbourne, P., Winqvist, R., Kunert, E., Davies, J., Leisti, J., Thiele, H., et al. Unstable DNA may be responsible for the incomplete pene-trance of the myotonic distrophy phenotype. Hum Mol Gen 1992; 1: 467-473.

Monckton D, Wong L. J., Ashizawa T, & Caskey T. Somatic mosaicism, germline expansions, germline reversions and intergenerational reduc-tions in myotonic dystrophy males: small pool PCR analises. Hum Mol Genet 1995; 4 (1): 1-8

Harper P. Myotonic Dystrophy as a Trinucleotide Repeat Disorder-A Clinical Perspective. En: Wells R, Warren S, ed. California: Academic Press. 1998: 115-130.

Die-Smulders C, Höweler C, Thijs C, Mirandolle J, Anten H, Smeets H, et al. Age and causes of death in adult-onset myotonic dystrophy. Brain 1998; 121: 1557-1563.

Keriakos R, Aziz & Sidra L. Myotonic dystrophy in pregnancy. Jour-nal of Obstetrics and Gynecology 1999; 19 (1): 71-73.

Golbus M, Simpson J. Genetics in Obstetrics & Gynecology. 2da ed. México: Saunders, 1992.

Milunsky A. Genetic disorders and the fetus. 3ra ed. Baltimore: The Johns Hopkins University Press, 1992.

Deka R, Majumder P, Shriver M, Stiver D, Zhong Y, Yu M L, et al. Dis-tribution and evolution of CTG repeats at the myotonin protein kinase gene in human populations. Genome Res 1996; 6: 142-154.

Thornton C, Griggs R, Moxley R. Myotonic Dystrophy with no trinu-cleotide repeat expansion. Ann Neurol 1994; 35: 269-272.

Abbruzzesse C, Krahe R, Liguori M, Tessarolo D, Siciliano M, Ashi-zawa T, et al. Myotonic dystrophy phenotipe wihtout expansion of (CGT)n Repeat: an entity distinct from proxomal miotonic myopathy (PROMM)? J Neurol 1996; 243: 715-721.

Rannum L, Rasmussen P, Benzow K, Koob DM, Day WJ. Genetic mapping of a second myotonic distrophy locus. Nat Genet 1998; 19: 196-198.

Ricker K. Myotonic dystrophy and proximal miotonic myopathy. J Neurol 1999; 146: 334-338.

Ricker K, Grimm T, Koch MC, Schneider C, Kress W, Reimers CD, et al. Linkage of proximal myotonic myopathy to chomosome 3q. Neuro-logy 1999; 59: 170-171.

Koty P, Pegoraro E, Hobson G, Marks HG, Turel A, Flagler D, et al. Myotonia and the muscle chloride channel: dominant mutations show variable penetrance and founder effect. Neurology 1996; 47: 963-968

Downloads

Published

2001-10-01

How to Cite

Molecular diagnosis of Myotonic Dystrophy (DM) in Costa Rica. (2001). Acta Médica Costarricense , 43(4), 159-167. https://doi.org/10.51481/amc.v43i4.75